Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 1997;50:110-117; doi:10.1136/jcp.50.2.110
Copyright © 1997 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.

K Yashima, M A Piatyszek, H M Saboorian, A K Virmani, D Brown, J W Shay and A F Gazdar

Hamon Centre for Therapeutic Oncology Research, UT Southwestern Medical Centre, Dallas 75235-8593, USA.

AIMS/BACKGROUND: Telomerase, an enzyme associated with cellular immortality, is expressed by most malignant tumours, but is inactive in normal somatic cells except for male germ cells and proliferating stem cells. Thus, the measurement of telomerase activity in tissue samples may provide useful diagnostic and prognostic information. The aim of this study was to determine whether telomerase expression is useful for the detection of occult malignant cells in lymph nodes. METHODS: Telomerase activity was compared with histological findings in 123 surgically removed lymph nodes submitted for routine or frozen section diagnosis. Telomerase activity was measured using a modified, semi-quantitative PCR-based telomeric repeat amplification protocol (TRAP). The assay was adapted for single 5 microns OCT embedded cryostat sections. In either fresh tissues or cryostat sections, normalised activity was linear when compared with protein concentration. Furthermore, using an in situ hybridisation method, the human telomerase RNA (hTR) component was measured in a subset of negative and positive nodes. RESULTS: Most (96%) of the 97 histologically negative nodes expressed low levels of activity (mean value of positive samples = 3.0 units/microgram protein) which may be derived from activated lymphocytes that express telomerase activity. All 26 malignant nodes (17 metastases, nine lymphomas) expressed telomerase (mean value = 17.8 units/microgram protein). The rank order levels between the two groups differed significantly (p = 0.0002). In situ results showed clearly that the hTR was expressed relatively highly in metastatic cancer cells and at lower levels in germinal centres of secondary follicles. CONCLUSIONS: Although expression of telomerase by activated lymphocytes may limit its usefulness, measurement of enzyme activity combined with detection of hTR using in situ hybridisation may assist in the histopathological diagnosis of lymph nodes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • O'Flatharta, C, Leader, M, Kay, E, Flint, S R, Toner, M, Robertson, W, Mabruk, M J E M F (2002). Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation. J. Clin. Pathol. 55: 602-607 [Abstract] [Full Text]  
  • Shay, J. W., Zou, Y., Hiyama, E., Wright, W. E. (2001). Telomerase and cancer. Hum Mol Genet 10: 677-685 [Abstract] [Full Text]  
  • Aogi, K., Woodman, A., Urquidi, V., Mangham, D. C., Tarin, D., Goodison, S. (2000). Telomerase Activity in Soft-Tissue and Bone Sarcomas. Clin. Cancer Res. 6: 4776-4781 [Abstract] [Full Text]  
  • Günther, T., Schneider-Stock, R., Häckel, C., Pross, M., Schulz, H.-U., Lippert, H., Roessner, A. (2000). Telomerase Activity and Expression of hTRT and hTR in Gastrointestinal Stromal Tumors in Comparison with Extragastrointestinal Sarcomas. Clin. Cancer Res. 6: 1811-1818 [Abstract] [Full Text]  
  • Heine, B., Coupland, S. E, Kneiff, S., Demel, G., Bornfeld, N., Hummel, M., Stein, H. (2000). Telomerase expression in uveal melanoma. Br. J. Ophthalmol. 84: 217-223 [Abstract] [Full Text]  
  • Yi, X., Tesmer, V. M., Savre-Train, I., Shay, J. W., Wright, W. E. (1999). Both Transcriptional and Posttranscriptional Mechanisms Regulate Human Telomerase Template RNA Levels. Mol. Cell. Biol. 19: 3989-3997 [Abstract] [Full Text]  
  • Norrback, K.-F., Enblad, G., Erlanson, M., Sundstrom, C., Roos, G. (1998). Telomerase Activity in Hodgkin's Disease. Blood 92: 567-573 [Abstract] [Full Text]  
  • Curran, A. J., St. Denis, K., Irish, J., Gullane, P. J., MacMillan, C., Kamel-Reid, S. (1998). Telomerase Activity in Oral Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg 124: 784-788 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs